[US Stocks Alert] Kailera Therapeutics soars on October 9th: Phase III enrollment completed, clinical data released, and obesity drug progress
Bitget异动解读2026/10/09 15:25Kailera Therapeutics October 9 Surge Interpretation
Keywords: phase 3 enrollment completion, clinical data, obesity drugs
1. On September 30, the company announced the global KaiNETIC phase 3 project had completed enrollment, covering 3 trials and over 200 research centers. The primary objective is to evaluate weekly injections of the GLP-1/GIP dual receptor agonist lirupatide, with top-line data expected to be released in mid-2028.
2. On October 1, the company presented phase 1 data on lirupatide injection at the EASD 2026 conference. Among 51 trial participants, drug exposure levels after injections in the upper arm or thigh were similar to those after abdominal injections, and no new safety signals were observed. Additionally, the company’s partners submitted four relevant oral presentations.
(Disclaimer: This content is summarized and generated from publicly available information by AI technology. It is for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Micron expands stock repurchase plan to 35.16 billions USD
Micron Technology's board of directors has approved an expanded stock repurchase plan, which will take effect starting in December. According to Micron’s 10-K filing, the board “approved increasing the maximum amount of common stock that may be repurchased at the company’s discretion to $35.16 billion, effective December 9.” Previously, Micron had approved a $10 billion stock repurchase program, of which approximately $2.2 billion remained unused.
Dow Jones rises 0.83%, S&P 500 rises 0.59%, Nasdaq rises 0.64%
The Dow Jones closed up 0.83%, the Nasdaq rose 0.64%, and the S&P 500 gained 0.59%. Among the most actively traded stocks, Micron Technology fell 0.66%, Nvidia declined 0.52%, SpaceX increased 1.25%, and Tesla rose 2.05%.
Hurricane Isaias approaches, causing 72% of crude oil production in the Gulf of Mexico to halt
As Category 3 Hurricane Isaias approaches the U.S. Gulf Coast, local oil producers have suspended around 1.46 million barrels per day of crude oil production, accounting for 72% of the region's total output. According to the U.S. Bureau of Ocean Energy Management, as of 12:00 p.m. Eastern Time on Friday (midnight Beijing time on October 10), workers have been evacuated from 129 offshore platforms, and two mobile drilling rigs have been relocated out of the storm's path. BP has shut down production at the Thunder Horse and Na Kika platforms and evacuated non-essential personnel from three other platforms. The supply interruption has pushed Gulf of Mexico crude oil prices higher, with Mars crude currently carrying a premium of about $3 per barrel over WTI crude, and Thunder Horse crude maintaining a premium of more than $4 per barrel for two consecutive trading days.
Google internally tests AI model Carbon, employees say its programming capabilities rival Claude Opus 5.5
According to Business Insider, Google (GOOG.US) is internally testing a new AI model called Carbon, and employees say its programming capabilities are comparable to Claude Opus 5.5.
Crypto prices
More
